– Name Change for Heartburn Drug KapidexThe U.S. Food and Drug Administration a name change for the heartburn drug Kapidex was approved, with two with two other medications – Casodex and Kadian. Effective in April 2010, Takeda Pharmaceuticals North America Inc. Will market Kapidex under the new name Dexilant.
The FDA is pleased to and responsible Takeda to take swift and responsible action patient safety, the name of the product in the interest of patient safety, change, Janet Woodcock, director of the FDA Center for Drug Evaluation and Research, said the FDA evaluates new drug names before a product is approved, to avoid confusion with existing drugs to unexpected unexpected minimize confusion when the product goes to market. The role of glutamate in the pathophysiology of migraine Given the future migraine prophylaxis can in the modulation of one of the receptors in the glutamate system, are mGluR5. – At the annual meeting of the American Academy of Neurology in Seattle will present Phase IIa data on ADX10059, an mGluR5 negative allosteric modulator, which shows efficacy in treating acute migraine attacks and provides evidence that inhibition of this glutamate receptor subtype in stopping in stopping migraine attacks before they start..On 1 Jul. 2009 no advertising material and indicator from tobacco products in retail are allowed. The position of the Celebrity tobacco in the retail play an role in encouraging tobacco consumption. Seine located near everyday consumer how newspapers and sweets help of tobacco a further benign consumer product to be seen. Research shows annually at POS tobacco advertising an important factor of a young Person Starting from smoking allowed and further. If young people can be prevented from the purchase of tobacco product, there is less chance they are become addicted and suffering in a smoking room disease. On advertising are to quit even adults who try to.